nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bioinformatics framework for targeted gene expression assay design: Application to in vitro developmental neurotoxicity screening in a rat model
|
Padhi, Bhaja K. |
|
|
133 |
C |
p. |
artikel |
2 |
Acute and sub chronic toxicity studies with herbal pain relieving formula (Rhuleave-K™) in rats
|
Antony, Benny |
|
|
133 |
C |
p. |
artikel |
3 |
A double-blind, randomized, two-part, two-period crossover study to evaluate the pharmacokinetics of caffeine versus d9-caffeine in healthy subjects
|
Sherman, Mary M. |
|
|
133 |
C |
p. |
artikel |
4 |
Application of a new approach method (NAM) for inhalation risk assessment
|
Ramanarayanan, Tharacad |
|
|
133 |
C |
p. |
artikel |
5 |
Assessment of the applicability of the threshold of toxicological concern for per- and polyfluoroalkyl substances
|
Lea, Isabel A. |
|
|
133 |
C |
p. |
artikel |
6 |
Comparison of product safety data sheet ingredient lists with skin irritants and sensitizers present in a convenience sample of light-curing resins used in additive manufacturing
|
Bowers, Lauren N. |
|
|
133 |
C |
p. |
artikel |
7 |
Comparison of the lower limit of benchmark dose confidence interval with no-observed-adverse-effect level by applying four different software for tumorigenicity testing of pesticides in Japan
|
Yasuhiko, Yukuto |
|
|
133 |
C |
p. |
artikel |
8 |
Corrigendum to “An OECD TG 428 study ring trial with 14C-Caffeine demonstrating repeatability and robustness of the dermal absorption in vitro method” [Regul. Toxicol. Pharmacol. 132 (2022) 105184]
|
Kluxen, Felix M. |
|
|
133 |
C |
p. |
artikel |
9 |
Current ecotoxicity testing needs among selected U.S. federal agencies
|
Ceger, Patricia |
|
|
133 |
C |
p. |
artikel |
10 |
Editorial Board
|
|
|
|
133 |
C |
p. |
artikel |
11 |
In vitro and in vivo evaluation of probiotic potential and safety assessment of Bacillus coagulans SKB LAB-19 (MCC 0554) in humans and animal healthcare
|
Chaudhari, Khushal |
|
|
133 |
C |
p. |
artikel |
12 |
Monosodium glutamate in a type 2 diabetes context: A large scoping review
|
El Tabbal, Jana |
|
|
133 |
C |
p. |
artikel |
13 |
Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines
|
Stjepanovic, Ana N. |
|
|
133 |
C |
p. |
artikel |
14 |
Physiologically based pharmacokinetic combined JAK2 occupancy modelling to simulate PK and PD of baricitinib with kidney transporter inhibitors and in patients with hepatic/renal impairment
|
Wang, Zhongjian |
|
|
133 |
C |
p. |
artikel |
15 |
Preclinical safety evaluation of the ethanolic extract from the aerial parts of Gomphrena celosioides Mart. in rodents
|
Macorini, Luis Fernando Benitez |
|
|
133 |
C |
p. |
artikel |
16 |
Quantitative measurement of harmful and potentially harmful constituents, pH, and moisture content in 16 commercial smokeless tobacco products
|
Edwards, Selvin H. |
|
|
133 |
C |
p. |
artikel |
17 |
Richardia brasiliensis Gomes: phytochemical characterization, antiproliferative capacity and in vitro and in vivo toxicity
|
Dornelles, Rafaela Castro |
|
|
133 |
C |
p. |
artikel |
18 |
Safety assessment of MPTA: An oral acute and 90-day sub-chronic toxicity study in Sprague-Dawley rats
|
Dong, Zhen |
|
|
133 |
C |
p. |
artikel |
19 |
The ability of sweat and buffer solutions to reduce hexavalent chromium of relevance for leather extraction
|
Wright, Alexandra |
|
|
133 |
C |
p. |
artikel |
20 |
Toxicity assessment and health hazard classification of stainless steels
|
Taxell, Piia |
|
|
133 |
C |
p. |
artikel |
21 |
Toxicological assessment of enzyme-treated Zizania latifolia extract: Oral toxicology and genotoxicity in rats
|
Park, Se-Ho |
|
|
133 |
C |
p. |
artikel |
22 |
Updated interim reference levels for dietary lead to support FDA's Closer to Zero action plan
|
Flannery, Brenna M. |
|
|
133 |
C |
p. |
artikel |
23 |
Updating the Dermal Sensitisation Thresholds using an expanded dataset and an in silico expert system
|
Chilton, Martyn L. |
|
|
133 |
C |
p. |
artikel |